We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Twenty five state attorneys general pushed back against a request by Purdue Pharma to suspend all litigation against the company and the Sackler family, arguing in two multistate filings that the family can well afford to proceed with the court cases. Read More
In a win for OSI Pharmaceuticals, the U.S. Court of Appeals for the Federal Circuit reversed a ruling by the Patent Trial and Review Board that overturned OSI’s patent for non-small cell lung cancer drug Tarceva (erlotinib). Read More
Democratic presidential hopeful Pete Buttigieg unveiled a drug pricing proposal on Monday that’s not just a cut-and-paste of the bill recently announced by his party colleagues in Congress. Read More
Nevada’s Department of Health and Human Services sent penalty letters last week to 21 drugmakers — totaling $17.4 million — for failing to file pricing reports on their diabetes drugs. Read More
Attorneys general from than two dozen states pushed back against Purdue Pharma’s plan to pay employees $38 million in bonuses, in a joint filing with the U.S. Bankruptcy Court in the Southern District of New York. Read More